News Author: HT Staff Publish date: October 22, 2014
A multicenter study showed that roughly 1 in 5 physicians did not know when a hospitalized patient had a central venous catheter (CVC) in place.
Ho...
News Author: HT Staff Publish date: October 22, 2014
Credit: Petr Kratochvil
Medical practices in less competitive markets charge more for their services, according to a study published in JAMA.
Th...
News Author: HT Staff Publish date: October 22, 2014
Credit: NCI
The trend of hospitals consolidating medical groups and physician practices is increasing the cost of patient care, new research sugges...
News Author: HT Staff Publish date: October 21, 2014
Credit: Thomas Semkow
Blocking the action of an enzyme “switch” needed to activate tumor growth may be a practical strategy for treating T-cell acu...
News Author: HT Staff Publish date: October 21, 2014
Credit: Salk Institute
Researchers say they can use induced pluripotent stem cells (iPSCs) to produce large-scale quantities of universal donor pla...
News Author: HT Staff Publish date: October 21, 2014
Control System
The US Food and Drug Administration has expanded the indication for the iTClamp® Hemorrhage Control System.
It is now approved to...
News Author: HT Staff Publish date: October 21, 2014
The findings, based on blood samples from nearly 3000 patients, don’t necessarily mean that people with these mutations will develop leukemia or lymph...
News Author: HT Staff Publish date: October 20, 2014
to a megakaryocyte (red)
Credit: Meng Zhao
For the first time, researchers have shown that hematopoietic stem cells (HSCs) can be directly control...
News Author: HT Staff Publish date: October 20, 2014
Calvin, who was diagnosed
with Pitt-Hopkins Syndrome
via trio-CES
Credit: Lapidus family
A 3-pronged approach to clinical exome sequencing (CES)...
News Author: HT Staff Publish date: October 19, 2014
Credit: Graham Colm
In a large study, whole-exome sequencing provided 25% of patients with a diagnosis related to a known genetic disease, giving y...
News Author: HT Staff Publish date: October 18, 2014
Credit: Steven Harbour
The European Commission has granted marketing approval for the Bruton’s tyrosine kinase inhibitor ibrutinib (Imbruvica) in t...
News Author: HT Staff Publish date: October 17, 2014
Credit: Bjorn Onfelt/Dan Davis
Inhibiting STAT3 in natural killer (NK) cells can kill leukemia in two ways, according to research published in Bloo...
News Author: HT Staff Publish date: October 17, 2014
Photo courtesy of the Gu lab
Biomedical engineers have developed a drug delivery system in which cancer cells are “tricked” into absorbing nanoscal...
News Author: HT Staff Publish date: October 17, 2014
Credit: NIGMS
A new way to control genes may provide a better understanding of cancers and aid the development of new therapies.
The key to the ...
News Author: HT Staff Publish date: October 17, 2014
A novel technique can jump-start the creation of blood vessels, researchers have reported in Nature Biotechnology.
The team used human embryonic st...
